Cardiovascular Preventive Care and Coordination of Care in Prostate Cancer Survivors: A Multi-Institutional Prospective Study

Jordan A. Holmes, Roger F. Anderson, Leroy G. Hoffman, Timothy N. Showalter, Mohit Kasibhatla, Sean P. Collins, Michael A. Papagikos, Brittany D. Barbosa, Kristy Alligood, Lori J. Stravers, Zahra Mahbooba, Andrew Z. Wang, Ronald C Chen

Research output: Contribution to journalArticle

Abstract

Purpose: Prostate cancer survivors who receive androgen deprivation therapy (ADT) are at increased risk of cardiovascular disease. They require coordinated care between cancer specialists and primary care physicians to monitor for cancer control and manage cardiovascular risk factors. Methods and Materials: We prospectively enrolled 103 men receiving ADT with radiation therapy (RT) from 7 institutions to assess cardiovascular risk factors and survivorship care. Medical records, fasting laboratory test values, and patient-reported outcomes using a validated instrument were assessed at baseline (pretreatment) and 1 year post-RT. Results: Cardiovascular disease (39%) and risk factors (diabetes, 22%; hypertension, 63%; hyperlipidemia, 31%) were prevalent at baseline. During the first year after RT completion, 63% received cardiovascular monitoring concordant with American Heart Association guidelines. Fasting laboratory test values at 1 year showed 24% with inadequately controlled blood sugar and 22% elevated cholesterol. Patient perceptions about care coordination were relatively low. At 1 year, 57% reported that their primary care physicians “always know about the care I receive at other places,” 67% reported that their cancer physician “communicated with other providers I see,” and 65% reported that the cancer care physician “knows the results of my visits with other doctors.” Conclusions: Patients with prostate cancer who receive ADT and RT are a vulnerable population with prevalent baseline cardiovascular disease and risk factors and suboptimal survivorship care specifically related to coordinated care and cardiovascular monitoring. Clinical trials examining ways to improve the care and outcomes of these survivors are needed.

LanguageEnglish (US)
Pages112-115
Number of pages4
JournalInternational Journal of Radiation Oncology Biology Physics
Volume103
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Preventive Medicine
Survivors
Prostatic Neoplasms
physicians
Radiotherapy
cancer
Prospective Studies
deprivation
Androgens
Cardiovascular Diseases
radiation therapy
Primary Care Physicians
fasting
therapy
Fasting
Neoplasms
Survival Rate
Physicians
Vulnerable Populations
Hypercholesterolemia

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Cardiovascular Preventive Care and Coordination of Care in Prostate Cancer Survivors : A Multi-Institutional Prospective Study. / Holmes, Jordan A.; Anderson, Roger F.; Hoffman, Leroy G.; Showalter, Timothy N.; Kasibhatla, Mohit; Collins, Sean P.; Papagikos, Michael A.; Barbosa, Brittany D.; Alligood, Kristy; Stravers, Lori J.; Mahbooba, Zahra; Wang, Andrew Z.; Chen, Ronald C.

In: International Journal of Radiation Oncology Biology Physics, Vol. 103, No. 1, 01.01.2019, p. 112-115.

Research output: Contribution to journalArticle

Holmes, JA, Anderson, RF, Hoffman, LG, Showalter, TN, Kasibhatla, M, Collins, SP, Papagikos, MA, Barbosa, BD, Alligood, K, Stravers, LJ, Mahbooba, Z, Wang, AZ & Chen, RC 2019, 'Cardiovascular Preventive Care and Coordination of Care in Prostate Cancer Survivors: A Multi-Institutional Prospective Study', International Journal of Radiation Oncology Biology Physics, vol. 103, no. 1, pp. 112-115. https://doi.org/10.1016/j.ijrobp.2018.07.2018
Holmes, Jordan A. ; Anderson, Roger F. ; Hoffman, Leroy G. ; Showalter, Timothy N. ; Kasibhatla, Mohit ; Collins, Sean P. ; Papagikos, Michael A. ; Barbosa, Brittany D. ; Alligood, Kristy ; Stravers, Lori J. ; Mahbooba, Zahra ; Wang, Andrew Z. ; Chen, Ronald C. / Cardiovascular Preventive Care and Coordination of Care in Prostate Cancer Survivors : A Multi-Institutional Prospective Study. In: International Journal of Radiation Oncology Biology Physics. 2019 ; Vol. 103, No. 1. pp. 112-115.
@article{198ef267d46b4dac9ec8337251cdb300,
title = "Cardiovascular Preventive Care and Coordination of Care in Prostate Cancer Survivors: A Multi-Institutional Prospective Study",
abstract = "Purpose: Prostate cancer survivors who receive androgen deprivation therapy (ADT) are at increased risk of cardiovascular disease. They require coordinated care between cancer specialists and primary care physicians to monitor for cancer control and manage cardiovascular risk factors. Methods and Materials: We prospectively enrolled 103 men receiving ADT with radiation therapy (RT) from 7 institutions to assess cardiovascular risk factors and survivorship care. Medical records, fasting laboratory test values, and patient-reported outcomes using a validated instrument were assessed at baseline (pretreatment) and 1 year post-RT. Results: Cardiovascular disease (39{\%}) and risk factors (diabetes, 22{\%}; hypertension, 63{\%}; hyperlipidemia, 31{\%}) were prevalent at baseline. During the first year after RT completion, 63{\%} received cardiovascular monitoring concordant with American Heart Association guidelines. Fasting laboratory test values at 1 year showed 24{\%} with inadequately controlled blood sugar and 22{\%} elevated cholesterol. Patient perceptions about care coordination were relatively low. At 1 year, 57{\%} reported that their primary care physicians “always know about the care I receive at other places,” 67{\%} reported that their cancer physician “communicated with other providers I see,” and 65{\%} reported that the cancer care physician “knows the results of my visits with other doctors.” Conclusions: Patients with prostate cancer who receive ADT and RT are a vulnerable population with prevalent baseline cardiovascular disease and risk factors and suboptimal survivorship care specifically related to coordinated care and cardiovascular monitoring. Clinical trials examining ways to improve the care and outcomes of these survivors are needed.",
author = "Holmes, {Jordan A.} and Anderson, {Roger F.} and Hoffman, {Leroy G.} and Showalter, {Timothy N.} and Mohit Kasibhatla and Collins, {Sean P.} and Papagikos, {Michael A.} and Barbosa, {Brittany D.} and Kristy Alligood and Stravers, {Lori J.} and Zahra Mahbooba and Wang, {Andrew Z.} and Chen, {Ronald C}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.ijrobp.2018.07.2018",
language = "English (US)",
volume = "103",
pages = "112--115",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Cardiovascular Preventive Care and Coordination of Care in Prostate Cancer Survivors

T2 - International Journal of Radiation Oncology Biology Physics

AU - Holmes, Jordan A.

AU - Anderson, Roger F.

AU - Hoffman, Leroy G.

AU - Showalter, Timothy N.

AU - Kasibhatla, Mohit

AU - Collins, Sean P.

AU - Papagikos, Michael A.

AU - Barbosa, Brittany D.

AU - Alligood, Kristy

AU - Stravers, Lori J.

AU - Mahbooba, Zahra

AU - Wang, Andrew Z.

AU - Chen, Ronald C

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: Prostate cancer survivors who receive androgen deprivation therapy (ADT) are at increased risk of cardiovascular disease. They require coordinated care between cancer specialists and primary care physicians to monitor for cancer control and manage cardiovascular risk factors. Methods and Materials: We prospectively enrolled 103 men receiving ADT with radiation therapy (RT) from 7 institutions to assess cardiovascular risk factors and survivorship care. Medical records, fasting laboratory test values, and patient-reported outcomes using a validated instrument were assessed at baseline (pretreatment) and 1 year post-RT. Results: Cardiovascular disease (39%) and risk factors (diabetes, 22%; hypertension, 63%; hyperlipidemia, 31%) were prevalent at baseline. During the first year after RT completion, 63% received cardiovascular monitoring concordant with American Heart Association guidelines. Fasting laboratory test values at 1 year showed 24% with inadequately controlled blood sugar and 22% elevated cholesterol. Patient perceptions about care coordination were relatively low. At 1 year, 57% reported that their primary care physicians “always know about the care I receive at other places,” 67% reported that their cancer physician “communicated with other providers I see,” and 65% reported that the cancer care physician “knows the results of my visits with other doctors.” Conclusions: Patients with prostate cancer who receive ADT and RT are a vulnerable population with prevalent baseline cardiovascular disease and risk factors and suboptimal survivorship care specifically related to coordinated care and cardiovascular monitoring. Clinical trials examining ways to improve the care and outcomes of these survivors are needed.

AB - Purpose: Prostate cancer survivors who receive androgen deprivation therapy (ADT) are at increased risk of cardiovascular disease. They require coordinated care between cancer specialists and primary care physicians to monitor for cancer control and manage cardiovascular risk factors. Methods and Materials: We prospectively enrolled 103 men receiving ADT with radiation therapy (RT) from 7 institutions to assess cardiovascular risk factors and survivorship care. Medical records, fasting laboratory test values, and patient-reported outcomes using a validated instrument were assessed at baseline (pretreatment) and 1 year post-RT. Results: Cardiovascular disease (39%) and risk factors (diabetes, 22%; hypertension, 63%; hyperlipidemia, 31%) were prevalent at baseline. During the first year after RT completion, 63% received cardiovascular monitoring concordant with American Heart Association guidelines. Fasting laboratory test values at 1 year showed 24% with inadequately controlled blood sugar and 22% elevated cholesterol. Patient perceptions about care coordination were relatively low. At 1 year, 57% reported that their primary care physicians “always know about the care I receive at other places,” 67% reported that their cancer physician “communicated with other providers I see,” and 65% reported that the cancer care physician “knows the results of my visits with other doctors.” Conclusions: Patients with prostate cancer who receive ADT and RT are a vulnerable population with prevalent baseline cardiovascular disease and risk factors and suboptimal survivorship care specifically related to coordinated care and cardiovascular monitoring. Clinical trials examining ways to improve the care and outcomes of these survivors are needed.

UR - http://www.scopus.com/inward/record.url?scp=85055557369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055557369&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2018.07.2018

DO - 10.1016/j.ijrobp.2018.07.2018

M3 - Article

VL - 103

SP - 112

EP - 115

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 1

ER -